Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of ACT-774312 in bilateral nasal polyposis
2018-000851-42Phase 2Completed
- Sponsor
- Idorsia
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic rhinosinusitis with nasal polyps (CRSwNP) comparing ACT-774312 with Placebo (2 arms). Primary endpoint: Change in nasal polyp score at Week 12. Started Jun 2018; status: completed.
02
Drugs
ACT-774312
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on 2018-000851-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000851-42.